Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
This research explores the role of hypothalamic dysfunction as a potential mechanism and biomarker in Alzheimer's disease development among individuals with Down syndrome. The study contributes to understanding neuropathological pathways specific to this population, which shows elevated Alzheimer's risk due to trisomy 21.
Individuals with Down syndrome have significantly elevated risk for early-onset Alzheimer's disease due to trisomy 21-related pathophysiology. Precision medicine approaches aim to tailor interventions based on individual genetic and biochemical profiles to improve outcomes in this high-risk population.
This article addresses reproductive health and fertility outcomes in individuals with Down syndrome. The topic examines the biological and medical factors affecting reproductive capacity in this population.
This research investigates how the APOE4 genetic variant influences Alzheimer's disease neuropathological changes in individuals with Down syndrome. The study provides molecular insights into why individuals with Down syndrome have elevated risk for early-onset Alzheimer's disease.
This research investigates the timing and pattern of cognitive and functional decline across different developmental domains in individuals with Down syndrome. The study identifies age-related deterioration in specific areas, providing important insights for clinical monitoring and intervention planning throughout the lifespan.